ID: h-bf78d35ce1
Hypothesis
Thalamic Reticular Nucleus (TRN) GluN2B Hyperexcitability Disrupts AQP4 Polarization
Excessive GluN2B signaling in TRN GABAergic neurons generates pathological delta-frequency oscillations that dysregulate local astrocyte calcium.
🧬 GRIN2B (TRN neurons); AQP4 polarization via SNTA1🩺 neuroscience🎯 Composite 63%💱 $0.57▼10.8%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
Excessive GluN2B signaling in TRN GABAergic neurons generates pathological delta-frequency oscillations that dysregulate local astrocyte calcium. Sustained astroglial calcium dysregulation via IP3R2 pathways disrupts AQP4 mRNA translation and M1-muscarinic receptor-mediated AQP4 anchor protein expression, mislocalizing AQP4 and reducing perivascular CSF-ISF exchange.
🧬 Mechanism
🔗 Mechanism from KG for GRIN2B (TRN neurons); AQP4 polarization via SNTA1
Auto-built from this analysis's top knowledge-graph edges.
graph TD
GluN2B["GluN2B"] -->|regulates| thalamic_burst_firing["thalamic burst firing"]
slow_wave_oscillations["slow-wave oscillations"] -->|enhances| glymphatic_clearance["glymphatic_clearance"]
tau_pathology["tau_pathology"] -.->|inhibits| glymphatic_clearance_effi["glymphatic clearance efficiency"]
Trem2["Trem2"] -->|regulates| tau_phagocytosis["tau phagocytosis"]
TREM2_deficiency["TREM2 deficiency"] -->|associated with| Tau_Clearance["Tau Clearance"]
Cx3Cl1["Cx3Cl1"] -->|associated with| Cx3Cr1["Cx3Cr1"]
Cx3Cr1_1["Cx3Cr1"] -->|regulates| tau_phagocytosis_2["tau phagocytosis"]
Memantine["Memantine"] -->|enhances| CSF_tracer_clearance["CSF tracer clearance"]
GluN2B_3["GluN2B"] -->|associated with| cortical_slow_wave_oscill["cortical slow-wave oscillations"]
oxidative_stress["oxidative_stress"] -->|causes| AQP4_oxidation["AQP4 oxidation"]
GLUTAMATE_EXCITOTOXICITY["GLUTAMATE EXCITOTOXICITY"] -->|enhances| Tau_Secretion["Tau Secretion"]
sess_SRB_2026_04_28_h_var["sess_SRB-2026-04-28-h-var-e2b5a7e7db_task_9aae8fc5"] -->|causal extracted| processed["processed"]
style GluN2B fill:#4fc3f7,stroke:#333,color:#000
style thalamic_burst_firing fill:#4fc3f7,stroke:#333,color:#000
style slow_wave_oscillations fill:#4fc3f7,stroke:#333,color:#000
style glymphatic_clearance fill:#81c784,stroke:#333,color:#000
style tau_pathology fill:#ef5350,stroke:#333,color:#000
style glymphatic_clearance_effi fill:#4fc3f7,stroke:#333,color:#000
style Trem2 fill:#4fc3f7,stroke:#333,color:#000
style tau_phagocytosis fill:#4fc3f7,stroke:#333,color:#000
style TREM2_deficiency fill:#4fc3f7,stroke:#333,color:#000
style Tau_Clearance fill:#4fc3f7,stroke:#333,color:#000
style Cx3Cl1 fill:#4fc3f7,stroke:#333,color:#000
style Cx3Cr1 fill:#4fc3f7,stroke:#333,color:#000
style Cx3Cr1_1 fill:#4fc3f7,stroke:#333,color:#000
style tau_phagocytosis_2 fill:#4fc3f7,stroke:#333,color:#000
style Memantine fill:#ce93d8,stroke:#333,color:#000
style CSF_tracer_clearance fill:#ce93d8,stroke:#333,color:#000
style GluN2B_3 fill:#4fc3f7,stroke:#333,color:#000
style cortical_slow_wave_oscill fill:#4fc3f7,stroke:#333,color:#000
style oxidative_stress fill:#4fc3f7,stroke:#333,color:#000
style AQP4_oxidation fill:#4fc3f7,stroke:#333,color:#000
style GLUTAMATE_EXCITOTOXICITY fill:#4fc3f7,stroke:#333,color:#000
style Tau_Secretion fill:#4fc3f7,stroke:#333,color:#000
style sess_SRB_2026_04_28_h_var fill:#4fc3f7,stroke:#333,color:#000
style processed fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
⚖️ Evidence Matrix3 supports2 contradicts
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — GRIN2B
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for GRIN2B (TRN neurons); AQP4 polarization via SNTA1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.5%
Volatility
Low
0.0020
Events (7d)
2
Price History
▼10.8%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF we pharmacologically antagonize GluN2B (e.g., ifenprodil 10 mg/kg i.p., daily for 14 days) in 9-12 month old APP/PS1 mice with established amyloid deposition, THEN perivascular AQP4 immunostaining | Significant restoration of AQP4 polarization ratio (perivascular/parenchymal) from ~0.3 baseline to >0.7 | — no observation — | pending | 0.65 |
| IF we perform bilateral TRN optogenetic inhibition (ArchT, 532 nm, 30 Hz, 2h during sleep) while simultaneously measuring glymphatic clearance using intrathecal Texas Red-dextran (MW 10 kDa) in IP3R2 | Cortex/medulla fluorescence ratio decrease of >50% in IP3R2 cKO vs. controls, indicating impaired glymphatic CSF-ISF exchange | — no observation — | pending | 0.55 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF we pharmacologically antagonize GluN2B (e.g., ifenprodil 10 mg/kg i.p., daily for 14 days) in 9-12 month old APP/PS1 mice with established amyloid deposition, THEN perivascular AQP4 immunostaining colocalized with PDGFRB+ astrocyte endfeet will increase by >40% compared to vehicle-treated control
Predicted outcome: Significant restoration of AQP4 polarization ratio (perivascular/parenchymal) from ~0.3 baseline to >0.7
Falsification: AQP4 polarization ratio remains <0.4 after GluN2B antagonism, or polarization is restored equally by systemic vehicle, indicating the effect is non-specific or independent of TRN GluN2B.
pendingconf 55%
IF we perform bilateral TRN optogenetic inhibition (ArchT, 532 nm, 30 Hz, 2h during sleep) while simultaneously measuring glymphatic clearance using intrathecal Texas Red-dextran (MW 10 kDa) in IP3R2 conditional knockout mice, THEN tracer clearance from cortex will be >50% reduced compared to Cre-ne
Predicted outcome: Cortex/medulla fluorescence ratio decrease of >50% in IP3R2 cKO vs. controls, indicating impaired glymphatic CSF-ISF exchange
Falsification: No significant difference in tracer clearance between IP3R2 cKO and controls; or clearance improves in cKO with optogenetic TRN inhibition, indicating IP3R2-independent pathway dominates.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.